Skip Navigation



JAC Advance Access published online on October 29, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm403
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/1/64    most recent
dkm403v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Valverde, A.
Right arrow Articles by Cantón, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valverde, A.
Right arrow Articles by Cantón, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Complex molecular epidemiology of extended-spectrum ß-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid

Aránzazu Valverde1, Teresa M. Coque1, Lucía García-San Miguel2, Fernando Baquero1 and Rafael Cantón1,*

1 Servicio de Microbiología, Hospital Universitario Ramón y Cajal and CIBER-ESP, Madrid, Spain 2 Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain

Received 6 July 2007; returned 15 August 2007; revised 17 August 2007; accepted 25 September 2007


* Corresponding author. Tel: +34-91-3368330; Fax: +34-91-3368809; E-mail: rcanton.hrc{at}salud.madrid.org

Objectives: To analyse all extended-spectrum-ß-lactamase (ESBL)-producing Klebsiella pneumoniae isolates recovered from 2001 to 2004 in our institution and to compare this period with that of 1989 to 2000.

Methods: All K. pneumoniae isolates recovered during the studied period were screened for ESBL production. One isolate per patient was selected for ESBL characterization and for population structure, including phylogenetic groups, and plasmid analysis.

Results: Ninety-three (3.2% mean) ESBL-producing K. pneumoniae isolates recovered from 61 patients (26%, medical wards; 18%, surgical wards; 25%, ICU; and 31%, outpatients) were identified. Outpatients significantly increased (P < 0.01) when compared with 1989–2000 (7%). The number of different ESBLs increased with persistence of previously identified enzymes (TEM-4, SHV-2, CTX-M-9 and CTX-M-10) and emergence of new ESBLs (TEM-110, SHV-11, SHV-12, CTX-M-14 and CTX-M-15). A polyclonal structure, including epidemic clones with specific ESBLs (TEM-4, SHV-12 and CTX-M-15), was observed. Phylogenetic analysis showed that most isolates (74.6%) belonged to KpI-type with a clear relationship between KpIII-type and CTX-M-10 producers. Persistence of specific plasmids associated with specific ESBLs (TEM-4, SHV-12, CTX-M-10 and CTX-M-15) was observed. Co-resistance analysis revealed an increment in resistance to trimethoprim (41.5% versus 10.3%), sulphonamide (54.7% versus 29.3%) and nalidixic acid (34.0% versus 6.9%) when compared with 1989–2000.

Conclusions: K. pneumoniae is still an important ESBL producer in our institution with a complex epidemiology. The main features were a few outbreaks with persistence of specific plasmids, emergence of new enzymes and an increment in community isolates. These results should be taken into account for the implementation of epidemiological containment measures.

Key Words: ESBLs , K. pneumoniae , long-term studies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. Oteo, O. Cuevas, I. Lopez-Rodriguez, A. Banderas-Florido, A. Vindel, M. Perez-Vazquez, V. Bautista, M. Arroyo, J. Garcia-Caballero, P. Marin-Casanova, et al.
Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults
J. Antimicrob. Chemother., September 1, 2009; 64(3): 524 - 528.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A.-M. Tarkkanen, T. Heinonen, R. Jogi, S. Mentula, M. E. van der Rest, C. J. Donskey, T. Kemppainen, K. Gurbanov, and C. E. Nord
P1A Recombinant {beta}-Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2455 - 2462.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Valverde, F. Grill, T. M. Coque, V. Pintado, F. Baquero, R. Canton, and J. Cobo
High Rate of Intestinal Colonization with Extended-Spectrum-{beta}-Lactamase-Producing Organisms in Household Contacts of Infected Community Patients
J. Clin. Microbiol., August 1, 2008; 46(8): 2796 - 2799.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.